Skip to main content

Related news

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

Related professionals

Alba Estela García Fernández

Alba Estela García Fernández

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Veronica Estepa Calvo

Veronica Estepa Calvo

Research technician
Reconstructive Surgery of the Locomotor System
Read more
Zuleika del Carmen Gonzalez Ramos

Zuleika del Carmen Gonzalez Ramos

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Paula Fernández Álvarez

Paula Fernández Álvarez

Research technician
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.